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1. Introduction 
Alkanes produced from polyunsaturated fatty 
acids have been detected in exhaled air in experimen- 
tal animals, and the measurement of alkane exhala- 
tion has been proposed as an index for lipid peroxida- 
tion [l]. Correlations between lipid peroxidation and 
in vivo ethane or pentane production have been made 
with intact animals [l-6], and this parameter is gen- 
erally considered useful for non-invasive monitoring 
in toxicological studies (cf. review [7]). The increased 
formation of malondialdehyde [ 1,6] and diene con- 
jugation [8] together with decreased levels of gluta- 
thione [6] in the liver are in support of the assumption 
that the liver is the main site for alkane production. 
However, direct evidence for hepatic alkane produc- 
tion is lacking. Therefore, we have modified the sys- 
tem of non-recirculating hemoglobin-free perfusion of 
rat liver [9] to permit measurement of hepatic alkane 
production. 
In this work, we have studied alkane release under 
a variety of conditions including the metabolism 
of t-butyl hydroperoxide, paraquat and ethanol. 
Parallel determination of glutathione disulfide release 
showed that ethane formation provides useful infor- 
mation also for the isolated organ. In particular, this 
experimental system may be suited for assessment of 
the influence of metabolic manipulations on the pro- 
cess of lipid peroxidation in the liver. 
2. Experimental 
Livers from male Wistar rats (130-200 g body wt) 
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fed on stock diet (Altromin), were perfused at 37°C 
as in [9] without recirculation of the perfusate (open 
system), using the bicarbonate-buffered salt solution 
[lo] equilibrated with Oa/COa (19/l, v/v). Where 
indicated, the perfusion medium also contained, as 
sodium salts, Llactate (2.1 mM) and pyruvate 
(0.3 mM). Perfusate flow (4-S ml . min-’ . g liver 
wet wt-‘) was maintained constant throughout the 
individual experiment. [O,] in the effluent was moni- 
tored with a Clark-type electrode, and care was taken 
to maintain X.2 mM O2 to avoid pericentral hypoxia. 
The perfusion table was fitted with a 13.5 ml cyclin- 
drical plexiglass chamber, serving as a collection 
chamber for evolved alkanes. Sampling was per- 
formed through a sampling port using Hamilton gas- 
tight syringes. Further, the effluent perfusate was col- 
lected into a 1.5 litre and a 1 .O litre vessel (heated to 
60°C) connected in series. The gas phases above 0.5 
litre of stirred perfusate in these vessels were also ana- 
lysed for alkanes. Thus, by addition of the amount of 
alkane released from the liver surface into the plexi- 
glass chamber and of the amount of alkane found in 
the gas phases above the 2 vessels, the total amount of 
alkane produced by the organ was determined. 
Gas chromatography was performed with a Carlo 
Erba model 215 1 AC Fractovap chromatograph, 
equipped with a Porasil C column, essentially as in 
[7,1 I]. The system was calibrated with calibration gas 
(ethane, 0.69 ppm; propane, 0.82 ppm; n-butane, 
0.62 ppm; n-pentane, 0.66 ppm) provided by Messer- 
Griesheim (Duisburg). In preliminary experiments 
using the perfusion apparatus as described, but with- 
out a liver, it was ascertained that unspecific absorp- 
tion of alkanes to the surfaces or leakage of alkanes 
from the apparatus was negligible, even in the pmol 
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range of interest with the liver perfusion. Glutathione 
efflux from the liver was detected as in [ 121. 
t-Butyl hydroperoxide was a gift from Peroxid- 
Chemie (HGllriegelskreuth), paraquat was from Fluka 
(Buchs), and diethylmaleate was from Merck 
(Darmstadt). Other chemical and biochemicals were 
from Boehringer (Mannheim) or Merck (Darmstadt). 
3. Results 
3.1. Alkane evolution from perfused liver into COlleCtiOn 
chamber and the release with effluent perfusate 
When massive lipid peroxidation was initiated by 
infusion of FeClz (0.26 mM), alkanes were released 
from the surface of the perfused liver into the air space 
of the collection chamber, amounting to 0.7 pmol . 
min-’ . g liver wet wt-’ for ethane and pentane (not 
shown). In other types of initiation of lipid peroxida- 
tion, much less alkane is produced (see below), and in 
those circumstances the metabolism of the gases gen- 
erated by the liver may become significant. Therefore, 
we have examined the rate of disappearance of the 
calibration gas mixture when added into the collec- 
tion chamber. As shown in fig.1, propane, n-butane 
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Fig.1. Changes in alkane content in collection chamber equil- 
ibrated with the calibration gas mixture (see section 2) in the 
presence of a perfused liver from a fed rat. Without a liver in 
the chamber, the lines were practically horizontal. 
and n-pentane disappear from the chamber when a 
perfused liver is also present, whereas without the 
organ there are no changes in alkane content. Ethane, 
however, showed a net accumulation due to signifi- 
cant production by the liver as is discussed further 
below. 
The partitioning between the evolution from the 
liver surface and the release into the effluent perfu- 
sate was determined in 7 different perfusion experi- 
ments. The amount of ethane observed in the collec- 
tion chamber was remarkably invariant, amounting to 
7.1 f 1 .O% of the total alkane release. Further, this 
percentage did not depend on the rate of ethane pro- 
duction within the range studied here. Therefore, it 
was considered acceptable to express the results from 
the accumulated chamber concentration in terms of 
rates of ethane production per gram liver wet weight 
per minute by using this factor (table 1, fig.24). It is 
noted that this implies the assumption of a homoge- 
neous response of the organ with respect to ethane 
production. 
3.2. Ethane release during metabolism of ethanol and 
of drug substrates 
The release of ethane from the liver amounted to 
1.4 pmol . min . g liver wet wt-‘, and a slightly lower 
value was consistently found with livers from rats 
pretreated with phenobarbital, 1 g/litre drinking 
water for at least 7 days (table 1). These rates of 
ethane production could account for those observed 
with intact rats in previous studies. For example, 
ethane production in rats fed a control diet was 
-400 pmol . h-l . 100 g body wt-’ 1.51, correspond- 
ing to 1.7 pmol . min-’ . g liver-’ with an assumed 
liver weight of 4 g/100 g body wt. Similar data from 
other groups were 0.3 [2] and 0.8 [3] pmol ethane . 
min-’ . g liver-‘. 
Table 1 
Ethane release from perfused rat liver 
Condition Additions Ethane production 
(pm01 min-’ g 
wet wt-‘) 
Control, fed None 1.42 t 0.33 (6) 
Ethanol (44 mM) 7.93 * 1.54 (4) 
Phenobarbital- None 0.85 + 0.09 (13) 
treated, fed Paraquat (3 mM) 4.20 + 1.41 (3) 
Data are given as means + SEM (n = number of different 
perfusion experiments) 
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Fig.2. Reversible increase in ethane release from perfused 
liver during infusion of ethanol. 
The increase in ethane release upon addition of an 
acute dose of ethanol is shown in fig.2 and table 1. 
The time course shows that the release of ethane is an 
early and reversible event, occurring a few minutes 
after the onset of the ethanol infusion, and well 
before the increased release of lactate dehydrogenase. 
The addition of some drugs to perfused hvers of 
phenobarbital-pretreated rats was also included. Para- 
quat, added to 3 mM, led to a rise in ethane formation 
of 4.2 pmol . min-’ . g wet wt-’ within a few minutes 
after onset of the infusion (table 1) in a time- 
course similar to that shown for ethanol. Since in 
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Fig.3. Ethane release from perfused liver from phenob~bit~- 
pretreated fed rat in the presence of paraquat. The perfusion 
medium contained lactate (2.1 mM) and pyruvate (0.3 mM) 
except for the period marked as substrate-free interval. Simi- 
lar experiments in which lactate and pyruvate were not added 
are reported in table 1. 
whole animal studies on ethane exhalation during 
paraquat intoxication no significant increase in 
ethane production was observed 113,141 except for 
the state of selenium deficiency [ 131, it was of inter- 
est to attempt modification of the production rates in 
A 
t-Butyl Hydroperoxide 
X 
B 
LO- 
3c- 
20- 
F 
& 
‘; .5 -- 
(UOI 
:: “lo- 
3-k 
ltE 
Perfusion Time imin) 
t -Butyl Hydroproxide 
I I 
gII 
,oz I 
5 -a 
0 
20 50 80 
Perfusion Time Iminl 
Fig.4 Ethane release and ~utathione efflux from perfused 
livers of fed rats in the presence of I-butyl hydroperoxide 
(0.3 mM) in controls (A) and after pretreatment with diethyl- 
maieate to deplete glutathione (B). 
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the isolated organ system. In fact, the addition of lac- 
tate and pyruvate to the perfusion medium substan- 
tially restricted paraquat-induced ethane formation 
by the liver (fig.3); however? when lactate and pyr- 
uvate were omitted, as indicated by the substrate-free 
interval from 56-76 min in fig.3, there was a swift 
increase in ethane formation, again well before a rise 
of lactate dehydrogenase activity in the effluent per- 
fusate. Such observation illustrates the potentiai use 
of this experimental system in assessing the role of 
metabolic manipulations in the control of the rate of 
lipid peroxidation. 
Under conditions of limitation in the capacity of 
the glutathione ‘defense system’ the addition of 
t-butyl hydroperoxide elicits the process of lipid per- 
oxidation in intact cells and subcellular fractions [12]. 
The experiments of fig.4 provide further information 
on this point; ethane released and glutathione efflux 
are compared for a control rat (A) and a rat in which 
liver giutathione was decreased to 25% of the control 
by prior treatment of the animal with diethyl male- 
ate, 6 mmol/lOO g body wt, 1 h prior to the experi- 
ment (B). com~red to (A), there is little ~utat~one 
disulfide release due to the lack of intracellular gluta- 
thione in (B) and concomitantly the rate of ethane 
production is substantially increased in (B). The ethane 
release in diethyimaleate-pretreated rats was not sig- 
nificantly above the control level, amounting to 
2.0 t 0.3 pm01 . min-* . g liver wet wt-‘. 
4. Conclusions 
These experiments demonstrate directly that iso- 
lated perfused liver produces alkanes, the rate of 
spontaneous ethane formation amounting to 
1.4 pm01 . min-” . g wet wt -I. The bulk of ethane 
exhaled from the intact animal can, therefore, be 
accounted for by hepatic production; this may be dif- 
ferent, however, if extrahepatic tissues heavily per- 
oxidize lipids in special cases. Using the paraquat- 
induced ethane release as an example, the system is 
shown to quaiify for further studies on the metabolic 
influences in the control of lipid perox~dation occur- 
ring with the intact organ. Further, topical inforrna- 
tion may be gained from simultaneously following 
other indicators such as malondialdehyde, or also 
chemiluminescence [ 151. The time-correlation 
between ethaue for~natioli and GSSG release as we11 
as the reversibility of both processes after cessation of 
infusion of oxidants demonstrate that an immediate 
metabolic response of the organ is measured by this 
tec~q~~e. 
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